X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (80) 80
index medicus (71) 71
male (68) 68
female (56) 56
middle aged (49) 49
aged (44) 44
warfarin (35) 35
cardiac & cardiovascular systems (33) 33
edoxaban (32) 32
double-blind method (31) 31
atrial fibrillation (29) 29
stroke (25) 25
treatment outcome (25) 25
risk factors (24) 24
adult (21) 21
peripheral vascular disease (20) 20
pyridines - therapeutic use (20) 20
thiazoles - therapeutic use (20) 20
abridged index medicus (19) 19
anticoagulants (18) 18
anticoagulants - therapeutic use (18) 18
factor xa inhibitors - therapeutic use (17) 17
risk (17) 17
disease (16) 16
analysis (15) 15
atrial fibrillation - drug therapy (15) 15
materials science, multidisciplinary (15) 15
warfarin - therapeutic use (15) 15
adolescent (14) 14
child, preschool (14) 14
clinical neurology (14) 14
hemorrhage - chemically induced (14) 14
stroke - prevention & control (14) 14
therapy (14) 14
child (13) 13
clinical trials (13) 13
medicine (13) 13
prevention (13) 13
pyridines - administration & dosage (13) 13
pyridines - adverse effects (13) 13
thiazoles - administration & dosage (13) 13
thiazoles - adverse effects (13) 13
atrial fibrillation - complications (12) 12
hematology (12) 12
management (12) 12
risk assessment (12) 12
time factors (12) 12
cohort studies (11) 11
factor xa inhibitors - adverse effects (11) 11
mutation (11) 11
patients (11) 11
anticoagulants - administration & dosage (10) 10
anticoagulants - adverse effects (10) 10
anticoagulation (10) 10
atrial-fibrillation (10) 10
dose-response relationship, drug (10) 10
factor xa inhibitors - administration & dosage (10) 10
follow-up studies (10) 10
medical research (10) 10
medicine, general & internal (10) 10
stroke - etiology (10) 10
young adult (10) 10
aged, 80 and over (9) 9
atherosclerosis (9) 9
bleeding (9) 9
care and treatment (9) 9
chemistry, physical (9) 9
dabigatran (9) 9
drug dosages (9) 9
factor xa inhibitor (9) 9
luminescence (9) 9
mortality (9) 9
nanoscience & nanotechnology (9) 9
neurosciences (9) 9
pediatrics (9) 9
safety (9) 9
ultrasonography (9) 9
warfarin - administration & dosage (9) 9
warfarin - adverse effects (9) 9
cardiac arrhythmia (8) 8
myocardial-infarction (8) 8
retrospective studies (8) 8
rivaroxaban (8) 8
thromboembolism (8) 8
venous thromboembolism (8) 8
chemistry, multidisciplinary (7) 7
drug therapy (7) 7
efficacy (7) 7
hemorrhage (7) 7
hypercholesterolemia (7) 7
internal medicine (7) 7
medicine, experimental (7) 7
muscular dystrophy (7) 7
neurology (7) 7
oral anticoagulants (7) 7
outcomes (7) 7
predicting stroke (7) 7
risk-factors (7) 7
thrombosis (7) 7
association (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Heart Journal, ISSN 0002-8703, 2010, Volume 160, Issue 4, pp. 635 - 641.e2
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10055, pp. 1995 - 2003
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9984, pp. 2280 - 2287
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 7, pp. 615 - 624
In a randomized trial, 1050 patients with cancer who had acute venous thromboembolism were assigned to receive either dalteparin or edoxaban for 6 to 12... 
PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | THROMBOSIS | VITAMIN-K ANTAGONISTS | TREATMENT GUIDELINES | Anticoagulants | Hematology | Embolisms | Pulmonary arteries | Body weight | Metastasis | Thrombosis | Cancer therapies | Bleeding | Medicine | Heparin | Thromboembolism | Health risk assessment | Drug dosages | Veins & arteries | Cancer
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 1372 - 1382
Abstract Background The use of non-vitamin K antagonist oral anticoagulants (NOACs) instead of vitamin K antagonists (VKAs) in patients with atrial... 
Cardiovascular | Internal Medicine | NOACs | valvular heart disease | atrial fibrillation | edoxaban | anticoagulation | warfarin | DEFINITION | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | RIVAROXABAN | PREVENTION | APIXABAN | DABIGATRAN | ESC GUIDELINES | NONVALVULAR ATRIAL-FIBRILLATION | EPIDEMIOLOGY | Stroke - prevention & control | Embolism - prevention & control | Double-Blind Method | Humans | Middle Aged | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Male | Thiazoles - therapeutic use | Warfarin - therapeutic use | Heart Valve Diseases - complications | Aged, 80 and over | Female | Aged | Hemorrhage - chemically induced | Pyridines - therapeutic use | Heart | Heart valve diseases | Anticoagulants (Medicine) | Cardiology | Atrial fibrillation | Cardiac patients | Medical research | Analysis | Aortic valve stenosis | Medicine, Experimental | Heart attack | Myocardial infarction | Cardiac arrhythmia | Stenosis | Cardiovascular disease | Antagonists | Bleeding | Confidence intervals | Fibrillation | Surgery | Regurgitation | Aorta | Rheumatic heart disease | Safety | Heart diseases | Vitamin K | Anticoagulants | Cerebral infarction | Stroke | Warfarin | Echocardiography | Effectiveness | Health risks | Hazards | Patients | Thrombolysis | Coronary artery disease | Heart valves | Infarction | Cardiovascular diseases
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2013, Volume 70, Issue 2, pp. 257 - 262.e3
Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 2018, Volume 118, Issue 8, pp. 1439 - 1449
In the Hokusai VTE Cancer study, edoxaban was non-inferior to dalteparin for the composite outcome of recurrent venous thromboembolism (VTE) and major bleeding... 
Stroke, Systemic or Venous Thromboembolism | direct oral anticoagulants | cancer | anticoagulant treatment | major bleeding | venous thromboembolism | THERAPY | RIVAROXABAN | EDOXABAN | PATTERNS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY
Journal Article
Biogeosciences, ISSN 1726-4170, 04/2017, Volume 14, Issue 8, pp. 2033 - 2054
Journal Article
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 01/2013, Volume 27, Issue 1, pp. e30 - e41
Journal Article